New England Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$6K Hold
50
﹤0.01% 1212
2014
Q3
$6K Hold
50
﹤0.01% 1221
2014
Q2
$5K Sell
50
-3
-6% -$309 ﹤0.01% 1305
2014
Q1
$5K Buy
53
+3
+6% +$271 ﹤0.01% 1251
2013
Q4
$5K Hold
50
﹤0.01% 1203
2013
Q3
$4K Hold
50
﹤0.01% 1226
2013
Q2
$4K Buy
+50
New +$3.74K ﹤0.01% 1093

Other funds holding ELV

New England Securities's ELV Position: Q4 2014 in Review

New England Securities held its Elevance Health (ELV) position steady in Q4 2014 at 50 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

New England Securities first reported a position in ELV in Q2 2013 and has held it in 7 quarters since. 719 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • New England Securities held 50 shares of Elevance Health worth $6K as of Q4 2014.
  • New England Securities left its Elevance Health share count unchanged in Q4 2014.
  • Elevance Health made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1212 holding.
  • New England Securities first reported a position in Elevance Health in Q2 2013 and has held it in 7 quarters since.
  • 719 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.